
Anne L. Holleran
Examiner (ID: 1384, Phone: (571)272-0833 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 775 |
| Issued Applications | 297 |
| Pending Applications | 125 |
| Abandoned Applications | 356 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5004533
[patent_doc_number] => 20070202101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Combination therapy using anti-EGFR antibodies and anti-hormonal agents'
[patent_app_type] => utility
[patent_app_number] => 11/789883
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14333
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789883 | Combination therapy using anti-EGFR antibodies and anti-hormonal agents | Apr 25, 2007 | Abandoned |
Array
(
[id] => 5004964
[patent_doc_number] => 20070202534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia'
[patent_app_type] => utility
[patent_app_number] => 11/796405
[patent_app_country] => US
[patent_app_date] => 2007-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8758
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202534.pdf
[firstpage_image] =>[orig_patent_app_number] => 11796405
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/796405 | CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia | Apr 25, 2007 | Issued |
Array
(
[id] => 5285361
[patent_doc_number] => 20090099036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'METHODS AND COMPOSITIONS FOR SCREENING GLYCAN STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 12/297384
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16729
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297384
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297384 | METHODS AND COMPOSITIONS FOR SCREENING GLYCAN STRUCTURES | Apr 17, 2007 | Abandoned |
Array
(
[id] => 4663581
[patent_doc_number] => 20080254488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Cancer Test'
[patent_app_type] => utility
[patent_app_number] => 11/735914
[patent_app_country] => US
[patent_app_date] => 2007-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8646
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254488.pdf
[firstpage_image] =>[orig_patent_app_number] => 11735914
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/735914 | Cancer Test | Apr 15, 2007 | Abandoned |
Array
(
[id] => 6219938
[patent_doc_number] => 20100055033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'ANTIBODY COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/296328
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29523
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296328
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296328 | Human monoclonal antibodies that bind human insulin like growth factors and their use | Apr 5, 2007 | Issued |
Array
(
[id] => 4797118
[patent_doc_number] => 20080008704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Methods of treating colorectal cancer with anti-epidermal growth factor antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/732204
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2775
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20080008704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11732204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/732204 | Methods of treating colorectal cancer with anti-epidermal growth factor antibodies | Apr 1, 2007 | Abandoned |
Array
(
[id] => 5091693
[patent_doc_number] => 20070231332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Inhibition of Cancer Metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/694370
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9045
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231332.pdf
[firstpage_image] =>[orig_patent_app_number] => 11694370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/694370 | Inhibition of Cancer Metastasis | Mar 29, 2007 | Abandoned |
Array
(
[id] => 5045606
[patent_doc_number] => 20070264279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Compositions and methods comprising a MAGE-b antigen'
[patent_app_type] => utility
[patent_app_number] => 11/727889
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28683
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11727889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/727889 | Compositions and methods comprising a MAGE-b antigen | Mar 27, 2007 | Abandoned |
Array
(
[id] => 4650995
[patent_doc_number] => 20080038251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'MN/CA IX and MAPK inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/726065
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14845
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11726065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/726065 | MN/CA IX and MAPK inhibition | Mar 19, 2007 | Abandoned |
Array
(
[id] => 5304114
[patent_doc_number] => 20090298766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'DETECTION AND TREATMENT OF CANCERS'
[patent_app_type] => utility
[patent_app_number] => 12/293124
[patent_app_country] => US
[patent_app_date] => 2007-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10561
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298766.pdf
[firstpage_image] =>[orig_patent_app_number] => 12293124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/293124 | DETECTION AND TREATMENT OF CANCERS | Mar 14, 2007 | Abandoned |
Array
(
[id] => 5225103
[patent_doc_number] => 20070254369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 11/679960
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9662
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679960
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679960 | METHODS AND APPARATUS FOR IDENTIFYING DISEASE STATUS USING BIOMARKERS | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5247327
[patent_doc_number] => 20070243561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA'
[patent_app_type] => utility
[patent_app_number] => 11/675958
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17510
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11675958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/675958 | PROGNOSTIC MARKERS IN CHRONIC LYMPHOCYTIC LEUKEMIA | Feb 15, 2007 | Abandoned |
Array
(
[id] => 5210388
[patent_doc_number] => 20070248972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/704714
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18696
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11704714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/704714 | Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor | Feb 8, 2007 | Abandoned |
Array
(
[id] => 5479587
[patent_doc_number] => 20090202544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Methods of Treating Diseases by Targeting Silt3'
[patent_app_type] => utility
[patent_app_number] => 12/223496
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 25547
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223496
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223496 | Methods of Treating Diseases by Targeting Silt3 | Feb 1, 2007 | Abandoned |
Array
(
[id] => 4682281
[patent_doc_number] => 20080248507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'C-erbB-2 external domain: GP75'
[patent_app_type] => utility
[patent_app_number] => 11/701352
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20684
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248507.pdf
[firstpage_image] =>[orig_patent_app_number] => 11701352
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/701352 | C-erbB-2 external domain: GP75 | Jan 31, 2007 | Abandoned |
Array
(
[id] => 5071784
[patent_doc_number] => 20070192886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'TAT-044 and methods of assessing and treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/699785
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 65029
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20070192886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699785
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699785 | TAT-044 and methods of assessing and treating cancer | Jan 29, 2007 | Abandoned |
Array
(
[id] => 5119355
[patent_doc_number] => 20070141069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Method for use of IGF-binding protein for selective sensitization of target cells in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/699047
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8610
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20070141069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699047 | Method for use of IGF-binding protein for selective sensitization of target cells in vivo | Jan 28, 2007 | Abandoned |
Array
(
[id] => 4932449
[patent_doc_number] => 20080003224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Compositions and methods for treating haematological proliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/699733
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 27390
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003224.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699733
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699733 | Compositions and methods for treating haematological proliferative disorders | Jan 28, 2007 | Abandoned |
Array
(
[id] => 5557768
[patent_doc_number] => 20090269345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'CLN248 Antibody Compositions and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/158729
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 48841
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269345.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158729 | CLN248 Antibody Compositions and Methods of Use | Dec 21, 2006 | Abandoned |
Array
(
[id] => 4964828
[patent_doc_number] => 20080107648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Therapeutic methods for inhibiting tumor growth with DII4 antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/639894
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7542
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20080107648.pdf
[firstpage_image] =>[orig_patent_app_number] => 11639894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/639894 | Therapeutic methods for inhibiting tumor growth with DII4 antagonists | Dec 14, 2006 | Abandoned |